Next-generation proteasome inhibitor approved in multiple myeloma

Nat Biotechnol. 2012 Nov;30(11):1011-2. doi: 10.1038/nbt1112-1011.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Oligopeptides / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Oligopeptides
  • benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal
  • carfilzomib